Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0NP8B
|
|||
| Former ID |
DIB009204
|
|||
| Drug Name |
ERIC-1
|
|||
| Synonyms |
UJ13A; NCAM antagonist, Imperial Cancer Research Technology; ERIC-1, ICRT; ERIC-1, Imperial CancerResearch Technology
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Terminated | [1] | |
| Company |
Imperial Cancer Research Technology Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Neural cell adhesion molecule (NCAM) | Target Info | Antagonist | [2] |
| KEGG Pathway | Cell adhesion molecules (CAMs) | |||
| Prion diseases | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004519) | |||
| REF 2 | Monoclonal antibody UJ13A recognizes the neural cell adhesion molecule (NCAM). Int J Cancer. 1989 Dec 15;44(6):1062-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.